Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2025-12-25 @ 5:06 AM
NCT ID:
NCT03300427
Eligibility Criteria:
Inclusion criteria:
* 40-80 years of age
* Chronic HF with reduced EF (left ventricle EF 25-35%) and NYHA class II-III symptoms.
* Systolic BP 110-160 mm Hg
* Optimal standard HF therapy according to European Society of Cardiology (ESC) guidelines at a stable dose for at least 4 weeks before the screening visit.
Exclusion criteria:
* Estimated glomerular filtration rate (eGFR) \< 45 ml/min
* Serum potassium \> 5.2 mmol/l and creatinine \>1.5 x ULN
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT03300427
Study Brief:
Protocol Section:
NCT03300427